[HTML][HTML] Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis

J Shen, S Yu, X Sun, M Yin, J Fei, J Zhou - Journal of ovarian research, 2019 - Springer
Background Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies.
Most OC patients are diagnosed in advanced stages with less than 40% of women cured …

Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.

J Shen, S Yu, X Sun, M Yin, J Fei… - Journal of Ovarian …, 2019 - europepmc.org
BACKGROUND: Ovarian cancer (OC) is the deadliest cause in the gynecological
malignancies. Most OC patients are diagnosed in advanced stages with less than 40% of …

[引用][C] Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis

J Shen, S Yu, X Sun, M Yin, J Fei… - Journal of Ovarian …, 2019 - jglobal.jst.go.jp
Identification of key biomarkers associated with development and prognosis in patients with
ovarian carcinoma: evidence from bioinformatic analysis | Article Information | J-GLOBAL Art …

Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.

J Shen, S Yu, X Sun, M Yin, J Fei… - Journal of Ovarian …, 2019 - search.ebscohost.com
Background: Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies.
Most OC patients are diagnosed in advanced stages with less than 40% of women cured …

[HTML][HTML] Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis

J Shen, S Yu, X Sun, M Yin… - Journal of …, 2019 - ovarianresearch.biomedcentral.com
Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies. Most OC
patients are diagnosed in advanced stages with less than 40% of women cured. However …

[HTML][HTML] Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis

J Shen, S Yu, X Sun, M Yin, J Fei… - Journal of Ovarian …, 2019 - ncbi.nlm.nih.gov
Background Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies.
Most OC patients are diagnosed in advanced stages with less than 40% of women cured …

Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis

J Shen, S Yu, X Sun, M Yin, J Fei… - Journal of ovarian …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies.
Most OC patients are diagnosed in advanced stages with less than 40% of women cured …

Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.

J Shen, S Yu, X Sun, M Yin, J Fei, J Zhou - Journal of Ovarian …, 2019 - go.gale.com
Background Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies.
Most OC patients are diagnosed in advanced stages with less than 40% of women cured …

[PDF][PDF] Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis

J Shen, S Yu, X Sun, M Yin, J Fei, J Zhou - 2019 - ovarianresearch.biomedcentral.com
Background: Ovarian cancer (OC) is the deadliest cause in the gynecological malignancies.
Most OC patients are diagnosed in advanced stages with less than 40% of women cured …